Patients at increased risk of MRSA infection
For patients with periorbital cellulitis who are systemically unwell in whom orbital cellulitis has been excluded and who are at increased risk of MRSA infection, use:
vancomycin intravenously; see Intermittent vancomycin dosing for noncritically ill adults or Intermittent vancomycin dosing for children for initial dosing. See advice on patient review, and modification and duration of therapy. vancomycin vancomycin vancomycin